GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Apex Healthcare Bhd (XKLS:7090) » Definitions » Valuation Rank

Apex Healthcare Bhd (XKLS:7090) Valuation Rank


View and export this data going back to 2000. Start your Free Trial

What is Apex Healthcare Bhd Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Apex Healthcare Bhd Valuation Rank Related Terms

Thank you for viewing the detailed overview of Apex Healthcare Bhd's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Apex Healthcare Bhd Business Description

Traded in Other Exchanges
N/A
Address
1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing and marketing of pharmaceutical products; Wholesale and distribution of pharmaceutical and healthcare products; and Corporate comprising investments, properties, and others.